European Commission Approves Genzyme’s Once-Daily, Oral Multiple Sclerosis Treatment Aubagio® (teriflunomide) Genzyme, 30 Aug 2013 Accessed on 13 Sep 2013 from http://news.genzyme.com/press-release/european-commission-approves-genzymes-once-daily-oral-multiple-sclerosis-treatment-aub. CommentRecommendBookmarkWatch